http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Lee, Soo Teik,Kim, Chung Hun 의과학연구소 1997 全北醫大論文集 Vol.21 No.1
Gastroparesis는 섭취된 음식물의 위내에서 지연배출로 인한, 미심, 구토, 식욕저하, 복, 조기포만감 및 팽만감 등의 위장증상을 주로 동반하는 소화기질환으로 당뇨병, 위부분절제술, 약물투여, 바이러스 감염 후에 발생될 수 있다. 위 내용물의 위내에서 배출속도는 내용물의 물리적 성격에 따라 좌우되고 위장증상을 악화시킬 수 있기 때문에 만성 gastroparesis환자들은 섭취하는 음식의 양과 질면에서 영양장애등의 여러 문제들을 일으킬 수 있지만 증상완화를 위한 식이요법과 영양학적인 접근에 대한 보고는 드물다. 이에 gastroparesis환자들의 식이의 문제점과 중요영양소의 결핍 유 뮤, 식단의 변화가 우장증상변화에 대한 효과를 평가하고자 하였다. 검사대상은 위장증상에 대한 점수 합계가 6점 이상 환자 중 6개월 이상된 8명 환자(평균나이 38.3세, 2명 postviral gastroparesis, 6명 idopathic gastroparesis)를 대상으로 하였다. 위장증상과 식이습관은 환자에 직접 설문조사에 의해, 영양상태는 Creatinie arm index(CAI), serumvitamin과 mineral, 혈액생화학검사를 통해 평가하였다. 칼로리가 비슷한 두 종류의 다른 음식[음식A(저지방, 정상 섬유소) 1067Kcal, 170g 탄수화물, 59g 단백, 53g 지방, 3g 섬유소]를 각각 5일씩 연2주간 영양사에 의해 제공된 뒤 각각의 음식섭취 전후의 증상의 변화에 대해 기록 비교 분석하였다. 식이습관:8명의 전체환경중 5명(72.5%)에소 고기, 어류, 과일들을 2명(25%)에서 우유제품, 모든 환자(8명, 100%)에서 알코올제품을 제한하고 있었으며 5명(72.5%)에서는 보조적인 vitamine/mineral제재를 투여받고 있었다. 영양상태 : 혈청내 vitamine B6(6명, 75%), vitamine B1(4명, 50%), 철분(3명, 37.5%)에 대한 검사결과는 정상이하의 수치를 보였으나 다른 혈청내 vitamins, minerals, CAI(107+17%)들은 정상범위에 있었다. 위장증상에 대한 식이의 효과 : Gastroparesis와 연관된 각각의 위장증상들에 음식제공전과 음식A와B 섭취기간동안에 증상변화의 정도에 따라 0점(무증상)에서 3점(정상생활 장해)까지 점수를 주어 비교분석하였다. 증상합계의 총점수는 음식B (4.3±0.9)에서 음식제공전(9.3±1.0)과 음식A에 비해 의미있게 개선되었다. 결론 : Gastroparesis환자들은 흔히 스스로 증상완화를 위해 음식제한을 하고 있으며 이로 인한 영양결핍이 발생할 위험을 가지고 있다. 정상지방과 저섬유소의 음식이 저지방과 정상섬유소의 음식에 비해 증상의 완화효과를 보였다. 본 연구결과 음식내 섬유소의 양이 위장증상의 발생에 중요한 역할을 하며, 식이요법이 gastroparesis환자의 효과적인 치료임을 제시한다.
만성 간질환 환자들의 간 기능 정도에 따른 내당능 장애(Glucose Intolerance)의 비교
이승옥,안득수,김대곤,이수택,안혁수 대한소화기학회 1999 대한소화기학회지 Vol.33 No.5
Background/Aims: We investigated correlation between the severity of liver disease and glucose intolerance. Additionally, we compared the rate of glucose intolerance between the patients with pure liver cirrhosis and non-insulin-dependent diabetes mellitus (NIDDM) preceded cirrhosis. Methods: We classified eighty patients with chronic liver disease from L1 to L3 according to the severity liver injury by biochemical factors and the patients with NIDDM preceded cirrhosis were classified into L3-D group. We measured HbA1C, serum insulin and C-peptide and carried out 100 g ora glucose tolerance tests (OGTT). Results: The rate of glucose intolerance was 35% in L2 group and 89% in L3 group, and the rate of diabetic range was 5% and 41%, respectively. In L3 group, fastin blood sugar and HbA1C were in normal range, but the increment of serum insulin, C-peptide and blood glucose in OGTT were higher than in L1 or L2 group. In L3-D group, fasting blood sugar and HbA1C were higher than normal and more increment of blood glucose after oral glucose load was observed than in L3. Significant difference in insulin or C-peptide level was not observed between L3 and L3-D. Conclusions: Glucose intolerance appears to be proportional to the severity of live injury in chronic liver disease. It suggests that OGTT can be an indicator of hepatic injury. We should carefully interpret the glucose intolerance in liver cirrhosis because it shows different pattern from NIDDM preceded cirrhosis.
Lee, Jun Haeng,Kim, Jae J,Hahm, Ki-Baik,Lee, Dong Ho,Kim, Nayoung,Kim, Sung Kook,Park, Jong Jae,Choi, Seok Reyol,Lee, Jong Hun,Lee, Soo Teik,Lee, Eun Hyun,Rhee, Jong Chul WJG Press 2006 World journal of gastroenterology Vol.12 No.17
<P>To compare ecabet sodium and cimetidine in relieving symptoms of functional dyspepsia.</P>
Lee, Seok,Kim, In Hee,Kim, Seong Hun,Kim, Sang Wook,Lee, Seung Ok,Lee, Soo Teik,Kim, Dae Ghon,Lee, Chang Seop,Choi, Chang Soo,Cho, Eun Young,Kim, Haak Cheoul S. Karger AG 2010 Intervirology Vol.53 No.3
<P><I>Objectives:</I> The authors compared the efficacies and tolerabilities of pegylated interferon-α<SUB>2a</SUB> (PEG-IFN-α<SUB>2a</SUB>) + ribavirin and pegylated interferon-α<SUB>2b</SUB> (PEG-IFN-α<SUB>2b</SUB>) + ribavirin for the initial treatment of chronic hepatitis C. <I>Methods:</I> A total of 126 treatment-naive patients (29.4% genotype 1, 70.6% genotype non-1) were treated with PEG-IFN-α<SUB>2a</SUB> 180 μg/week (group A, n = 79) or PEG-IFN-α<SUB>2b</SUB> 1.5 μg/kg/week (group B, n = 47) with ribavirin (800 mg/day for genotype non-1 or 1,000-1,200 mg/day for genotype 1) for 24 (genotype non-1) or 48 weeks (genotype 1). <I>Results:</I> End-of-treatment virologic response, sustained virologic response, and biochemical response were not significantly different in groups A and B (84.8 vs. 89.4%, 70.9 vs. 72.3%, and 70.9 vs. 74.5%, respectively; p > 0.05). In patients with the HCV genotype 1 or non-1, treatment responses were not significantly different. Multivariate analysis showed that HCV genotype only was an independent factor that affected sustained virologic response (p = 0.048). The proportions of treatment discontinuations in groups A and B were similar (10.1 vs. 10.6%; p = 1.000). <I>Conclusions:</I> PEG-IFN-α<SUB>2a</SUB> or PEG-IFN-α<SUB>2b</SUB> + ribavirin combination therapies showed similar efficacies and tolerabilities as initial treatments for chronic hepatitis C.</P><P>Copyright © 2010 S. Karger AG, Basel</P>
Lee, Eun-Hyun,Cheong, Jae Youn,Cho, Sung Won,Hahm, Ki-Baik,Kim, Hak Yang,Park, Jong-Jae,Lee, Dong Ho,Kim, Seong Kook,Choi, Seok Reyol,Lee, Soo Teik,Moon, Seong Mi Blackwell Publishing Asia 2008 Journal of Gastroenterology and Hepatology Vol.23 No.2
<P>Abstract</P><P>Background and Aims: </P><P>There has been no reliable and valid instrument to measure health-related quality of life for Asian patients with chronic liver disease. The aim of the present study was to develop and evaluate a chronic liver disease-specific quality of life (CLD-QOL) questionnaire for Korean patients with chronic liver disease.</P><P>Methods: </P><P>Content-validated items were evaluated psychometrically in 271 patients with chronic liver disease recruited from seven university hospitals in Korea. The participants were asked to complete a preliminary questionnaire comprising the content-validated items and the Short Form-36 Health Survey. The Child–Pugh classification was used to classify the severity of liver cirrhosis.</P><P>Results: </P><P>Factor analysis extracted a five-factor solution from 27 preliminary items, which were generated by an expert panel and a pilot study, but factor and a multidimensional scaling analysis revealed that four items were not loaded significantly on any factor, suggesting that the four items might be heterogeneous. After deletion of these four items, a multiscaling analysis strongly supported item convergence and discriminant validity. The CLD-QOL was associated significantly with the Child–Pugh classification and the type of patient status (inpatient/outpatient) and was moderately correlated with the subscales of the Short Form-36 Health Survey. The values of Cronbach's alpha for the subscales of the novel CLD-QOL questionnaire were all greater than 0.70.</P><P>Conclusions: </P><P>The novel CLD-QOL questionnaire we developed is an easily applicable tool that exhibits excellent psychometric properties for Korean patients with chronic liver disease. It is recommended for the CLD-QOL to apply for Asian patients with chronic liver disease.</P>